BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 14609587)

  • 21. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.
    Pizzetti F; Turazza FM; Franzosi MG; Barlera S; Ledda A; Maggioni AP; Santoro L; Tognoni G;
    Heart; 2001 Nov; 86(5):527-32. PubMed ID: 11602545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of total atrial conduction time estimated with tissue Doppler imaging for the development of new-onset atrial fibrillation after acute myocardial infarction.
    Antoni ML; Bertini M; Atary JZ; Delgado V; ten Brinke EA; Boersma E; Holman ER; van der Wall EE; Schalij MJ; Bax JJ; van de Veire NR
    Am J Cardiol; 2010 Jul; 106(2):198-203. PubMed ID: 20599003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.
    Kosmidou I; Liu Y; Zhang Z; Redfors B; Kappetein AP; Serruys PW; Gersh BJ; Kandzari DE; Morice MC; Buszman PE; Bochenek A; Schampaert E; Sabik JF; Ben-Yehuda O; Stone GW
    Am J Cardiol; 2020 Feb; 125(4):500-506. PubMed ID: 31813531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups.
    Tanne D; Gottlieb S; Hod H; Reicher-Reiss H; Boyko V; Behar S
    J Am Coll Cardiol; 1997 Nov; 30(6):1484-90. PubMed ID: 9362406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of type of atrial fibrillation on prognosis in acute myocardial infarction treated invasively.
    Podolecki T; Lenarczyk R; Kowalczyk J; Kurek T; Boidol J; Chodor P; Swiatkowski A; Sredniawa B; Polonski L; Kalarus Z
    Am J Cardiol; 2012 Jun; 109(12):1689-93. PubMed ID: 22440129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of atrial fibrillation in thrombolysed and non thrombolysed patients.
    Trappolini M; Scorza A; Chillotti FM; Trappolini F; Danese A; De Vito F; Luberti E; Angrisani L; Braucci S
    Minerva Cardioangiol; 2006 Aug; 54(4):471-9. PubMed ID: 17016418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.
    Rathore SS; Berger AK; Weinfurt KP; Schulman KA; Oetgen WJ; Gersh BJ; Solomon AJ
    Circulation; 2000 Mar; 101(9):969-74. PubMed ID: 10704162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction.
    Guenancia C; Toucas C; Fauchier L; Stamboul K; Garnier F; Mouhat B; Sagnard A; Lorgis L; Zeller M; Cottin Y
    Europace; 2018 Dec; 20(12):e179-e188. PubMed ID: 30060066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocardial infarction.
    Consuegra-Sánchez L; Melgarejo-Moreno A; Galcerá-Tomás J; Alonso-Fernández N; Díaz-Pastor Á; Escudero-García G; Jaulent-Huertas L; Vicente-Gilabert M
    Rev Esp Cardiol (Engl Ed); 2015 Jan; 68(1):31-8. PubMed ID: 25131442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
    Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
    Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related treatment strategy and long-term outcome in acute myocardial infarction patients in the PCI era.
    Kala P; Kanovsky J; Rokyta R; Smid M; Pospisil J; Knot J; Rohac F; Poloczek M; Ondrus T; Holicka M; Spinar J; Jarkovsky J; Dusek L
    BMC Cardiovasc Disord; 2012 Apr; 12():31. PubMed ID: 22533539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up.
    Berton G; Cordiano R; Cucchini F; Cavuto F; Pellegrinet M; Palatini P
    Int J Clin Pract; 2009 May; 63(5):712-21. PubMed ID: 19392921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary Flow Disturbance Phenomenon After Percutaneous Coronary Intervention Is Associated with New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction.
    Niiyama M; Koeda Y; Suzuki M; Shibuya T; Kinuta M; Tosaka K; Fujiwara J; Kanehama N; Sasaki W; Shimoda Y; Ishida M; Itoh T; Morino Y
    Int Heart J; 2021 Mar; 62(2):305-311. PubMed ID: 33731528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective.
    Goldberg RJ; Yarzebski J; Lessard D; Wu J; Gore JM
    Am Heart J; 2002 Mar; 143(3):519-27. PubMed ID: 11868060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    DeGeare VS; Boura JA; Grines LL; O'Neill WW; Grines CL
    Am J Cardiol; 2001 May; 87(9):1035-8. PubMed ID: 11348598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    Shihara M; Tsutsui H; Tsuchihashi M; Tada H; Kono S; Takeshita A;
    Am J Cardiol; 2002 Nov; 90(9):932-6. PubMed ID: 12398957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty.
    Yip HK; Wu CJ; Chang HW; Yang CH; Yu TH; Chen YH; Hang CL
    Chest; 2005 May; 127(5):1491-7. PubMed ID: 15888819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.